Evidence map›Paper›PMID 41113300›Full record

ArticleClinical case reports2025

Piperacillin Sodium and Tazobactam Sodium-Induced Neutropenia and Thrombocytopenia: A Case Report.

Hongyu Zhang, Kaile Wu, Ka Liang, Zheng Peng, Ping Yi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hongyu ZhangDepartment of Clinical Laboratory The Third Affiliated Hospital of Guangxi University of Chinese Medicine, Liuzhou Traditional Chinese Medical Hospital, The Third Clinical Faculty of Guangxi University of Chinese Medicine Liuzhou Guangxi China.ORCID https://orcid.org/0000-0002-2654-2380
Kaile WuDepartment of Clinical Laboratory The Third Affiliated Hospital of Guangxi University of Chinese Medicine, Liuzhou Traditional Chinese Medical Hospital, The Third Clinical Faculty of Guangxi University of Chinese Medicine Liuzhou Guangxi China.
Ka LiangDepartment of Clinical Laboratory The Third Affiliated Hospital of Guangxi University of Chinese Medicine, Liuzhou Traditional Chinese Medical Hospital, The Third Clinical Faculty of Guangxi University of Chinese Medicine Liuzhou Guangxi China.
Zheng PengDepartment of Clinical Laboratory The Third Affiliated Hospital of Guangxi University of Chinese Medicine, Liuzhou Traditional Chinese Medical Hospital, The Third Clinical Faculty of Guangxi University of Chinese Medicine Liuzhou Guangxi China.
Ping YiDepartment of Gastroenterology The Third Affiliated Hospital of Guangxi University of Chinese Medicine, Liuzhou Traditional Chinese Medical Hospital, The Third Clinical Faculty of Guangxi University of Chinese Medicine Liuzhou Guangxi China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Piperacillin sodium/tazobactam sodium (PIP-TAZ) is a commonly used antibiotic for various infections. While generally well-tolerated, it has been associated with rare cases of neutropenia and thrombocytopenia. This case report highlights the potential for PIP-TAZ to cause these adverse effects, emphasizing the importance of vigilant monitoring and timely intervention. A 79-year-old female with chronic renal failure and end-stage renal disease developed neutropenia and thrombocytopenia during treatment with PIP-TAZ for a suspected lung infection. Her neutrophil count plummeted from 11.17 × 10

Indexed as

case reportneutropeniapiperacillintazobactam drug combinationthrombocytopenia

Identifiers

PMID41113300
PMCPMC12529228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.